Xuejun Jiang: Featured News

Xuejun Jiang: Featured News

Share
Print
Share
Print
In the Lab
SKI cell biologists Junmei Yi and Xuejun Jiang
More Evidence that Cellular ‘Death by Iron’ Could Be Promising Avenue of Cancer Treatment
Cancers with certain mutations are vulnerable to ferroptosis, a form of iron-dependent cell death.
Finding
a man holding a shield and sword
Scientists See Potential in Cellular 'Death by Iron' for Cancer Treatment
This form of cell death is called ferroptosis, and certain cancer cells are especially vulnerable to it.
Novel Regulation of the Common Tumor Suppressor PTEN
Researchers led by scientists at Memorial Sloan Kettering Cancer Center have now identified fundamentally novel regulatory mechanisms of <i>PTEN</i> function. The findings from two related studies are published in the January 12 issue of <i>Cell</i>.
In the Lab
Pictured: BCG
Study Clarifies How Bladder Cancer Treatment Works
Researchers have shed light on how an important treatment for early-stage bladder cancer enters cancer cells to eradicate them.
Xuejun Jiang
At Work: Cell Biologist Xuejun Jiang
Xuejun Jiang heads a laboratory at the Sloan Kettering Institute, where he continues to help unlock the mysteries of programmed cell death.